Literature DB >> 8840856

Fibrous matrix of ventricular myocardium in tricuspid atresia compared with normal heart. A quantitative analysis.

S Y Ho1, M Jackson, L Kilpatrick, A Smith, L M Gerlis.   

Abstract

BACKGROUND: The collagen matrix is a small component of the myocardium, but it provides a supportive framework. An increase in collagen in the pressure-overloaded ventricle is known to cause myocardial stiffness. However, little is known about the collagen matrix in the volume-overloaded ventricle, particularly in relation to congenital heart disease. METHODS AND
RESULTS: We examined a total of 53 hearts with tricuspid atresia and 58 normal hearts matched for age. Using a microscopic-morphometric method, we analyzed the percentage per field area occupied by interstitial fibrous tissue in four sites in the ventricular mass for each specimen. A comparison of sampling sites showed no significant variations between normal and malformed hearts. Results from a homogeneity of regression co-efficients analysis suggested that the two groups shared the same basic relation of proportion of fibrosis with age. The use of ANCOVA, however, revealed a clear separation between the extents of fibrous tissue in the two groups of hearts.
CONCLUSIONS: The myocardium of hearts with tricuspid atresia is consistently more fibrotic than normal heart and is probably an inherent part of the malformation. This difference could explain, at least in part, the clinical observation that the left ventricle is frequently abnormal, even at an early age.

Entities:  

Mesh:

Year:  1996        PMID: 8840856     DOI: 10.1161/01.cir.94.7.1642

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Myoarchitecture and connective tissue in hearts with tricuspid atresia.

Authors:  D Sanchez-Quintana; V Climent; S Y Ho; R H Anderson
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

2.  Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study.

Authors:  Marcelo F Kozak; Andrew Redington; Shi-Joon Yoo; Mike Seed; Andreas Greiser; Lars Grosse-Wortmann
Journal:  Pediatr Radiol       Date:  2014-01-14

3.  Semiquantitative analysis of collagen types in the hypertrophied left ventricle.

Authors:  K A Linehan; A M Seymour; P E Williams
Journal:  J Anat       Date:  2001-01       Impact factor: 2.610

4.  Serial assessment of left ventricular diastolic function after Fontan procedure.

Authors:  Y F Cheung; D J Penny; A N Redington
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

5.  Toward 3-D Echocardiographic Determination of Regional Myofiber Structure.

Authors:  Michelle L Milne; Gautam K Singh; James G Miller; Kirk D Wallace; Mark R Holland
Journal:  Ultrasound Med Biol       Date:  2015-11-14       Impact factor: 2.998

Review 6.  Functional assessment for congenital heart disease.

Authors:  Yiu-Fai Cheung
Journal:  Korean Circ J       Date:  2014-03       Impact factor: 3.243

Review 7.  TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus.

Authors:  Fatemeh Yousefi; Zahra Shabaninejad; Sina Vakili; Maryam Derakhshan; Ahmad Movahedpour; Hamed Dabiri; Younes Ghasemi; Maryam Mahjoubin-Tehran; Azin Nikoozadeh; Amir Savardashtaki; Hamed Mirzaei; Michael R Hamblin
Journal:  Cell Commun Signal       Date:  2020-06-09       Impact factor: 5.712

Review 8.  Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design.

Authors:  Derek L Tran; Hannah Gibson; Andrew J Maiorana; Charlotte E Verrall; David W Baker; Melanie Clode; David R Lubans; Diana Zannino; Andrew Bullock; Suzie Ferrie; Julie Briody; Peter Simm; Vishva Wijesekera; Michelle D'Almeida; Sally E Gosbell; Glen M Davis; Robert Weintraub; Anthony C Keech; Rajesh Puranik; Martin Ugander; Robert Justo; Dominica Zentner; Avik Majumdar; Leeanne Grigg; Jeff S Coombes; Yves d'Udekem; Norman R Morris; Julian Ayer; David S Celermajer; Rachael Cordina
Journal:  Front Pediatr       Date:  2022-01-06       Impact factor: 3.418

9.  Myocardial fibrosis in congenital and pediatric heart disease.

Authors:  Jing Tian; Xinjiang An; Ling Niu
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.